RESÚMENES AGOSTO 2008

.

Other Neuropsychiatric Disorders & General Information

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

3! - Benzodiazepine and Risk of Hip Fractures in Older People: A Nested Case-Control Study in Taiwan

Chia-Ming Chang, Erin Chia-Hsuan Wu, I-Shou Chang, and Keh-Ming Lin

Am J Geriatr Psychiatry 16:686-692, August 2008

3 - A Prospective Study of Body Weight and Serum Leptin Levels in Patients Treated With Topiramate

Theisen, Frank M; Beyenburg, Stefan; Gebhardt, Stefan; Kluge, Michael; Blum, Werner F; Remschmidt, Helmut; Elger, Christian E; Hebebrand, Johannes

Clinical Neuropharmacology. 31(4):226-230, July/August 2008

3 - Treatment of Compulsive Buying

A.  Mueller, M.  de Zwaan

Fortschr Neurol Psychiatr 2008; 76: 478-483

3! - Apolipoprotein Eε4 Allele Genotype and the Effect of Depressive Symptoms on the Risk of Dementia in Men. The Honolulu-Asia Aging Study

Fumiko Irie, Kamal H. Masaki, Helen Petrovitch, Robert D. Abbott, G. Webster Ross, Dennis R. Taaffe, Lenore J. Launer, Lon R. White

Arch Gen Psychiatry. 2008;65(8):906-912

 

3! - Effects of poverty on cognitive function. A hidden neurologic epidemic

Donna C. Bergen

NEUROLOGY 2008;71:447-451

5 - Effect of fish oil on cognitive performance in older subjects. A randomized, controlled trial

O. van de Rest, J. M. Geleijnse, F. J. Kok, W. A. van Staveren, C. Dullemeijer, M.G.M. OldeRikkert, A. T.F. Beekman, and C. P.G.M. de Groot

NEUROLOGY 2008;71:430-438

GRATIS 3! - Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey

Juan J Llibre Rodriguez, Cleusa P Ferri, Daisy Acosta, Mariella Guerra, Yueqin Huang, KS Jacob, ES Krishnamoorthy, Aquiles Salas, Ana Luisa Sosa, Isaac Acosta, Michael E Dewey, Ciro Gaona, AT Jotheeswaran, Shuran Li, Diana Rodriguez, Guillermina Rodriguez, P Senthil Kumar, Adolfo Valhuerdi, Martin Prince and for the 10/66 Dementia Research Group

The Lancet. Volume 372, Issue 9637, 9 August 2008-15 August 2008, Pages 464-474

 

4 - Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: Post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect

Louis Mini, Sherry Wang-Weigand and Jeff Zhang

Clinical Therapeutics. Volume 30, Issue 7, July 2008, Pages 1316-1323

 

GRATIS 1! - Is early intervention in the major psychiatric disorders justified? Yes

Patrick D McGorry

BMJ 2008;337:a695

 

GRATIS 1! - Is early intervention in the major psychiatric disorders justified? No

Anthony Pelosi

BMJ 2008;337:a710

 

3 - Transcranial direct current stimulation improves recognition memory in Alzheimer disease

R. Ferrucci, F. Mameli, I. Guidi, S. Mrakic-Sposta, M. Vergari, S. Marceglia, F. Cogiamanian, S. Barbieri, E. Scarpini, and A. Priori

NEUROLOGY 2008;71:493-498

3! - Parasomnia Among Psychiatric Outpatients: A Clinical, Epidemiologic, Cross-Sectional Study

Siu P. Lam, Samson Y. Y. Fong, Crover K. W. Ho, Mandy W. M. Yu, and Yun K. Wing

J Clin Psychiatry August 12, 2008: e1-e9

 

5 - Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lars Lannfelt, Kaj Blennow, Henrik Zetterberg, StellanBatsman, David Ames, John Harrison, Colin L Masters, Steve Targum, Ashley I Bush, Ross Murdoch, Janet Wilson, Craig W Ritchie and on behalf of the PBT2-201-EURO study group

The Lancet Neurology. Volume 7, Issue 9, September 2008, Pages 779-786

 

5 - An examination of the effects of the antioxidant Pycnogenol® on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population

J. Ryan, K. Croft, T. Mori, K. Wesnes, J. Spong, L. Downey, C. Kure, J. Lloyd, C. Stough

Journal of Psychopharmacology, Vol. 22, No. 5, 553-562 (2008)

3 - Ramelteon: A Novel Approach in the Treatment of Insomnia

Jill N Reynoldson, Ellie SR Elliott, Leigh Anne Nelson

The Annals of Pharmacotherapy: Vol. 42, No. 9, pp. 1262-1271

GRATIS 3 - Intrathecal corticosteroids might slow Alzheimer’s disease progression

Joseph Martin Alisky

Neuropsychiatric Disease and Treatment. On Line Early, August 2008

 

3! - Riluzole in the Treatment of Mood and Anxiety Disorders

Pittenger, Christopher; Coric, Vladimir; Banasr, Mounira; Bloch, Michael; Krystal, John H; Sanacora, Gerard

CNS Drugs. 22(9):761-786, 2008

3! - Salivary cortisol and suicidal behaviorA follow-up study

Daniel Lindqvist, Anders Isaksson, Lil-Träskman-Bendz and Lena Brundin

Psychoneuroendocrinology. Volume 33, Issue 8, September 2008, Pages 1061-1068

 

GRATIS 3! - Risk profiles for mild cognitive impairment and progression to dementia are gender specific

S Artero, M-L Ancelin, F Portet, A Dupuy, C Berr, J-F Dartigues, C Tzourio, O Rouaud, M Poncet, F Pasquier, S Auriacombe, J Touchon, K Ritchie

Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:979-984

GRATIS 3 - Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study

J P Mostert, F Admiraal-Behloul, J M Hoogduin, J Luyendijk, D J Heersema, M A van Buchem, J De Keyser

Journal of Neurology, Neurosurgery, and Psychiatry 2008;79:1027-1031

3 - Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses

Alasdair M.J. MacLullich, Karen J. Ferguson, Thomas Miller, Sophia E.J.A. de Rooij and Colm Cunningham

Journal of Psychosomatic Research. Volume 65, Issue 3, September 2008, Pages 229-238

 

3 - Neuroimaging studies of delirium: A systematic review

Roy L. Soiza, Vijay Sharma, Karen Ferguson, Susan D. Shenkin, David Gwyn Seymour and Alasdair M.J. MacLullich

Journal of Psychosomatic Research. Volume 65, Issue 3, September 2008, Pages 239-248

 

3 - Predisposing and precipitating factors for delirium in a frail geriatric population

Jouko V. Laurila, Marja-Liisa Laakkonen, Jouko Valdemar Laurila, Strandberg E. Timo and Tilvis S. Reijo

Journal of Psychosomatic Research. Volume 65, Issue 3, September 2008, Pages 249-254

 

3! - Drug treatment of delirium: Past, present and future

Richard S. Bourne, Tayyeb A. Tahir, Mark Borthwick and Elizabeth L. Sampson

Journal of Psychosomatic Research. Volume 65, Issue 3, September 2008, Pages 273-282

 

3 - Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study

S Bellino, E Paradiso, P Bozzatello, and F Bogetto

Journal of Psychopharmacology First published on August 21, 2008

3! - Memantine in the treatment of binge eating disorder: An open-label, prospective trial

Brian P. Brennan, Jacqueline L. Roberts, Kate V. Fogarty, Karina A. Reynolds, Jeffrey M. Jonas, James I. Hudson

International Journal of Eating Disorders. Volume 41 Issue 6, Pages 520 - 526

 

3! - The influence of drug use on fall incidents among nursing home residents: a systematic review

Carolyn S. Sterke, Arianne P. Verhagen, Ed F. van Beeck and Tischa J. M. van der Cammen

International Psychogeriatrics (2008), 20:890-910

 

3 - The placebo treatments in neurosciences. New insights from clinical and neuroimaging studies

Nico J. Diederich, and Christopher G. Goetz

NEUROLOGY 2008;71:677-684

GRATIS 3! - Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis

Elmira Valiyeva, Nathan Herrmann, Paula A. Rochon, Sudeep S. Gill, and Geoffrey M. Anderson

CMAJ • August 26, 2008; 179 (5)

3 - Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--The Bergen District Nursing Home Study (BEDNURS)

Sabine Ruths, Jørund Straand, Harald A. Nygaard, Dag Aarsland

International Journal of Geriatric Psychiatry. Volume 23 Issue 9, Pages 889 - 895

 

3! - Depressive symptoms, vascular risk factors, and Alzheimer's disease

José A. Luchsinger, Lawrence S. Honig, Ming-Xin Tang, Devangere P. Devanand

International Journal of Geriatric Psychiatry. Volume 23 Issue 9, Pages 922 - 928

 

3 - Ethnicity and psychopharmacology

IB Chaudhry, K. Neelam, V. Duddu, N. Husain

Journal of Psychopharmacology, Vol. 22, No. 6, 673-680 (2008)

4 - Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6)

T. Erkinjuntti, S. Gauthier, R. Bullock, A. Kurz, G. Hammond, S. Schwalen, Y. Zhu, R. Brashear

Journal of Psychopharmacology, Vol. 22, No. 7, 761-768 (2008)

3 - Lamotrigine treatment of aggression in female borderline patients, Part II: an 18-month follow-up

P. Leiberich, MK Nickel, K. Tritt, F Pedrosa Gil

Journal of Psychopharmacology, Vol. 22, No. 7, 805-808 (2008)

GRATIS 3! - Exposure to antipsychotics and risk of stroke: self controlled case series study

Ian J Douglas, Liam Smeeth

BMJ 2008;337:a1227

 

3 - Transdermal Delivery of Treatment for Alzheimer's Disease: Development, Clinical Performance and Future Prospects

Chan, Agnes L F; Chien, Yie W; Jin Lin, Shun

Drugs & Aging. 25(9):761-775, 2008

GRATIS 4 - Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

Asquad Sultan, Helen Gaskell, Sheena Derry and R Andrew Moore

BMC Neurology 2008, 8:29

 

3! - The association between gambling pathology and personality disorders

Paul Sacco, Renee M. Cunningham-Williams, Emily Ostmann and Edward L. Spitznagel Jr.

Journal of Psychiatric Research. Volume 42, Issue 13, October 2008, Pages 1122-1130

.

Regresar a RESÚMENES AGOSTO 2008

.

© 1999-2008 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.